Explore: Biological Licence Application (BLA) | Clinical Trial Application Dossier | Narratives | New Drug Application (NDA) | Pregnancy Prevention Plan (or Programme, PPP) | Product Information (PI) | Statistical Analysis Plan (SAP) | Summary of Product Characteristics (SmPC) | United States Prescribing Information (USPI)

Other Documents

  • Clinical development programmes require a range of documentation, regulatory as well as non-regulatory, all of which Trilogy can provide.
  • Having writers from Trilogy involved from the early stages (e.g. preparing Clinical Development Plans, International Medicinal Product Dossiers or Investigational New Drug applications) means that thoughts and messages are clearly structured and presented from the beginning, which streamlines the writing of all later documents.
  • Utilizing a Trilogy team to prepare not only the main regulatory documents, but also supportive regulatory documents (e.g. subject narratives, Informed Consent Forms, Risk Management Plans, Periodic Safety Update Reports,) and documents based on information originating from regulatory documents (e.g. manuscripts, posters) ensures consistency and continuity – making the overall writing process more efficient.
  • Trilogy also has a team of writers who specialize in writing in plain language (and the company is PIF Tick accredited), and so we can help with all of your documentation needs.
  • All documents benefit from having been prepared by a professional medical writer.